GLAXOSMITHKLINE PHARMACEUTICALS
Back to Balance Sheet
|
GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Net Current Assets History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹1,827 Cr | ₹1,505 Cr | ₹1,273 Cr | ₹1,168 Cr | ₹2,009 Cr |
What is the latest Net Current Assets ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?
| Year | Net Current Assets |
|---|---|
| Mar2026 | ₹1,827 Cr |
| Mar2025 | ₹1,505 Cr |
| Mar2024 | ₹1,273 Cr |
| Mar2023 | ₹1,168 Cr |
| Mar2022 | ₹2,009 Cr |
How is Net Current Assets of GLAXOSMITHKLINE PHARMACEUTICALS Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,827 Cr | 21.42 | |
| Mar2025 | ₹1,505 Cr | 18.16 | |
| Mar2024 | ₹1,273 Cr | 9.04 | |
| Mar2023 | ₹1,168 Cr | -41.88 | |
| Mar2022 | ₹2,009 Cr | - | |
Compare Net Current Assets of peers of GLAXOSMITHKLINE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAXOSMITHKLINE PHARMACEUTICALS | ₹45,921.8 Cr | -1.3% | 0.2% | -6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹457,073.0 Cr | 8.1% | 9.3% | 9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹307,147.0 Cr | 10.5% | 18% | 51.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹181,626.0 Cr | 2.9% | 2.1% | 30.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹115,685.0 Cr | -0.1% | 16% | 14.6% | Stock Analytics | |
| CIPLA | ₹113,589.0 Cr | 1.4% | 8.1% | -6.8% | Stock Analytics | |
GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAXOSMITHKLINE PHARMACEUTICALS | -1.3% |
0.2% |
-6% |
| SENSEX | 5.5% |
13.3% |
-3.4% |
You may also like the below Video Courses